Literature DB >> 11114376

The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice.

W Shi1, A Kumanogoh, C Watanabe, J Uchida, X Wang, T Yasui, K Yukawa, M Ikawa, M Okabe, J R Parnes, K Yoshida, H Kikutani.   

Abstract

The class IV semaphorin CD100/Sema4D differentially utilizes two distinct receptors: plexin-B1 in nonlymphoid tissues, such as brain and kidney, and CD72 in lymphoid tissues. We have generated CD100-deficient mice and demonstrated that they have functional defects in their immune system, without apparent abnormalities in other tissues. The number of CD5(+) B-1 cells was considerably decreased in the mutant mice, whereas conventional B cells and T cells appeared to develop normally. In vitro proliferative responses and immunoglobulin production were reduced in CD100-deficient B cells. The humoral immune response against a T cell-dependent antigen and in vivo priming of T cells were also defective in the mutant mice. These results demonstrate nonredundant and essential roles of CD100-CD72 interactions in the immune system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114376     DOI: 10.1016/s1074-7613(00)00063-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  87 in total

Review 1.  Semaphorins as signals for cell repulsion and invasion.

Authors:  Yoshio Goshima; Takaaki Ito; Yukio Sasaki; Fumio Nakamura
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Neuronal migration and molecular conservation with leukocyte chemotaxis.

Authors:  Yi Rao; Kit Wong; Michael Ward; Claudia Jurgensen; Jane Y Wu
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

4.  Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Fumikazu Suto; Junko Kamei; Kazuhiro Aoki; Masanori Yabuki; Masatsugu Hori; Hajime Fujisawa; Hitoshi Kikutani
Journal:  Genes Dev       Date:  2004-02-20       Impact factor: 11.361

Review 5.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 6.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

7.  An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development.

Authors:  Suzanne Paradis; Dana B Harrar; Yingxi Lin; Alex C Koon; Jessica L Hauser; Eric C Griffith; Li Zhu; Lawrence F Brass; Chinfei Chen; Michael E Greenberg
Journal:  Neuron       Date:  2007-01-18       Impact factor: 17.173

Review 8.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 9.  The role of semaphorins in immune responses and autoimmune rheumatic diseases.

Authors:  Masayuki Nishide; Atsushi Kumanogoh
Journal:  Nat Rev Rheumatol       Date:  2017-12-07       Impact factor: 20.543

10.  The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.

Authors:  Deborah A Witherden; Megumi Watanabe; Olivia Garijo; Stephanie E Rieder; Gor Sarkisyan; Shane J F Cronin; Petra Verdino; Ian A Wilson; Atsushi Kumanogoh; Hitoshi Kikutani; Luc Teyton; Wolfgang H Fischer; Wendy L Havran
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.